851. Deputy Ken O'Flynn asked the Minister for Health the number of cases handled by the HSE stability and sustainability team since its establishment in 2022, broken down by year; the number of those cases that remain open; and whether a provider has exited the process due to closure or service withdrawal. [49275/26]
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
Showing questions asked by Ken O'Flynn .
3,835 questions match, newest first.
852. Deputy Ken O'Flynn asked the Minister for Health the total financial value of rejected PCRS claims for respiratory medicines that remained unpaid in each of the years 2020 t0 2025, and to date in 2026, broken down by year; the reason such a high proportion of rejected claims are never subsequently corrected or reclaimed; whether an assessment has been carried out into the impact of these unrecovered claims on pa…
853. Deputy Ken O'Flynn asked the Minister for Health the specific decision-making process by which the HSE determines that a drinking water exceedance constitutes a potential danger to human health requiring public-health intervention; the named office or role responsible for making that determination; and whether a documented threshold, beyond the WHO guideline value, triggers mandatory intervention. [49288/26]
854. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question No. 966 of 19 May 2026, the specific audit, consistency-review, or peer-review mechanism that apply to individual treatment abroad scheme eligibility determinations, and if no such mechanism exists, to confirm this directly (details supplied). [49296/26]
855. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question No. 984 of 19 May 2026, to confirm whether any internal audit, financial review, or governance assessment has in fact examined variations in treatment abroad scheme reimbursement costs between jurisdictions for comparable procedures (details supplied); and if no such examination has taken place, to confirm this directly. [49297/26…
856. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question No. 1117 of 19 May 2026, whether the HSE maintains a centralised database recording referrals abroad for gender-related care under the treatment abroad scheme; and if so, which HSE division is responsible for its governance and oversight (details supplied). [49298/26]
857. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question No. 996 of 19 May 2026, to explain the basis for the 2024 figures provided in reply, which show zero applications and zero approvals for paediatric gender-related treatment abroad scheme referrals in that year alongside 13 S2 authorisations issued and expenditure of €62,127.47; and to clarify whether this reflects multi-year proce…
858. Deputy Ken O'Flynn asked the Minister for Health if the HSE intends to introduce a national system for recording and tracking staff grievances and complaints, including time to resolution and referrals to the Workplace Relations Commission; if a timeline has been set for same; and if she will make a statement on the matter. [49303/26]
859. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Questions Nos. 774, 784, 785, 786 and 789 of 21 April 2026, to provide the definition of "clinical necessity" or "medical necessity" applied in approvals under the treatment abroad scheme, given that the reply to PQ23198/26 and related questions did not provide one. [49305/26]
860. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question No. 773 of 21 April 2026, to confirm whether the HSE maintains any database recording clinical outcomes for patients treated under the Treatment Abroad Scheme, given that the data referenced in the reply to PQ28074/26 relates only to activity and expenditure, not outcomes. [49306/26]
861. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question No's 774,784,785,786,789 of 21 April 2026, to identify the body or unit with national responsibility for clinical outcomes oversight under the Treatment Abroad Scheme, given that this was not addressed in the reply to PQ28106/26. [49307/26]
862. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question No's 774,784,785,786,789 and 788 of 21 April 2026, the mechanisms that exist to monitor follow-up care for patients returning to the State after Treatment Abroad Scheme procedures, given that the reply to PQ28076/26 and PQ28105/26 described only the application process, not post-treatment monitoring. [49308/26]
863. Deputy Ken O'Flynn asked the Minister for Health whether she accepts that confirmation of no clinical audits since 2020 represents a governance gap in the Treatment Abroad Scheme; and the steps she will take to close it. [49309/26]
864. Deputy Ken O'Flynn asked the Minister for Health whether the absence of a national definition of clinical necessity has been assessed for risk to patient safety or consistency of approvals across the State. [49310/26]
679. Deputy Ken O'Flynn asked the Minister for Health the test purchase inspections for nicotine inhaling products carried out by the National Environmental Health Service in each of years from 2024 to 2025, and to-date in 2026; the number of retailers found selling to children in each county; and the number of resulting prosecutions, by county, in tabular form. [46969/26]
680. Deputy Ken O'Flynn asked the Minister for Health the number of convictions secured arising from prosecutions for the sale of nicotine inhaling products to children in each of the years 2024 to 2025, and to- date in 2026; and the penalties imposed by the courts in each case. [46970/26]
681. Deputy Ken O'Flynn asked the Minister for Health the number of repeat offenders identified through the National Environmental Health Service test purchase programme for nicotine inhaling products since 2024; and whether consideration has been given to enhanced sanctions for repeat breaches. [46971/26]
687. Deputy Ken O'Flynn asked the Minister for Health whether the HSE centrally records the number of missed shifts by agency staff supplying workers to HSE-funded services; if so, the number of such missed shifts recorded in each of the past three years; and if she will make a statement on the matter. [47013/26]
688. Deputy Ken O'Flynn asked the Minister for Health whether the HSE maintains a central record of patient safety incidents involving agency staff supplying workers to HSE-funded services; if so, the number of such incidents recorded in each of the past three years; and if she will make a statement on the matter. [47014/26]
689. Deputy Ken O'Flynn asked the Minister for Health whether Garda vetting failures, lapses, or compliance gaps relating to agency staff supplying workers to HSE-funded services are centrally tracked and reported by the HSE; if so, the number recorded in each of the past three years; and if she will make a statement on the matter. [47015/26]
690. Deputy Ken O'Flynn asked the Minister for Health whether credentialing, qualification verification, registration, or professional compliance failures relating to agency staff supplying workers to HSE-funded services are centrally recorded by the HSE; if so, the number recorded in each of the past three years; and if she will make a statement on the matter. [47016/26]
691. Deputy Ken O'Flynn asked the Minister for Health whether contract breaches by staffing agencies operating under HSE national framework agreements or supplier panels are centrally logged by the HSE; if so, the number and nature of such breaches recorded in each of the past three years; and if she will make a statement on the matter. [47017/26]
692. Deputy Ken O'Flynn asked the Minister for Health the number of staffing agencies operating under HSE national framework agreements or supplier panels have been subject to sanctions, corrective actions, suspensions, removals from panels, financial penalties, or other enforcement measures in each of the past three years; the nature of those measures; and if she will make a statement on the matter. [47018/26]
884. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question No. 1088 of 19 May 2026, if the HSE will confirm whether it intends to develop a clinical definition of “obesity-related conditions” for measurement purposes; if the healthcare pricing office will expand the ICD-10-AM code set used for this analysis beyond E66.1, E66.2 and E66.9 to capture conditions where obesity is a recognised …
885. Deputy Ken O'Flynn asked the Minister for Health if the HSE will provide a breakdown by hospital group or CHO area of the discharges with a secondary diagnosis of obesity reported to HIPE for 2020 to 2025; and if the HSE will indicate the estimated cost to the public hospital system associated with these admissions. [47805/26]